-
Product Insights
Sinusitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Sinusitis pipeline market report provides a comprehensive overview of the therapeutics under development for Sinusitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Sinusitis and features dormant and discontinued...
-
Product Insights
Hepatitis C Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Hepatitis C occurs with multiple symptoms including abdominal pain, fatigue, fever, jaundice, loss of appetite, nausea, and vomiting. The predisposing factors of hepatitis C include dialysis, organ transplant, and blood transfusion. The Hepatitis C pipeline drugs market research report provides an analysis of the Hepatitis C drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The guide also covers the descriptive pharmacological action of the therapeutics, its complete research and development...
-
Company Insights
Balfour Beatty – Digital Transformation Strategies
Balfour Beatty plc. (Balfour Beatty) has been focusing on using drones, cloud and 3D models to digitally transform its operations. The annual ICT spending of Balfour Beatty was estimated at $172.4 million for 2021. A major share of this spending is earmarked for acquiring hardware, software, and ICT services from vendors. Balfour Beaty provides construction and infrastructure services. It offers construction and its related support services for infrastructure assets globally. The company’s service portfolio includes electrical and mechanical engineering, design...
-
Product Insights
Otitis Media Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Otitis media (OM) is any inflammation of the middle ear, the air-filled space behind the eardrum that contains the tiny vibrating bones of the ear. Symptoms include ear pain, difficulty sleeping, loss of balance, fever, headache, and loss of appetite. Risk factors include age, seasonal factors, and exposure to tobacco smoke or high levels of air pollution. Treatment includes antibiotics and antipyrine. The otitis media drugs in development market research report provides an overview of the Otitis Media pipeline landscape....
-
Product Insights
Burns Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
A Burn is damage to body's tissues caused by heat, chemicals, electricity, sunlight or radiation. Symptoms include pain, increasing with each degree of burn, red and swollen skin, blisters and charred and blackened skin. Treatment includes antibiotics and pain relievers. The Burn - Drugs in Development research report provides a comprehensive overview on the therapeutics under development for Burn, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The...
-
Consumer Insights
Flavor Preferences – Identifying Consumer Flavor Preferences and related Motivations
This report details the flavor preferences of consumers worldwide, broken down by age and region, across eight consumer goods categories, as well as exploring the motivations behind these flavor preferences and some case studies of unexpected flavor-product pairings from markets where those are popular. Health and wellness has driven consumers to look for flavors that resonate with the benefits of consuming nuts, berries, and citrus. Some flavor/product combinations are popular only in specific markets, like citrus in baked goods in...
-
Sector Analysis
Top Growth Opportunities: Hot Drinks in Canada
"Top Growth Opportunities: Hot Drinks in Canada", provides recommended actions and detailed analysis of how to target the best growth opportunities for Hot Drinks producers and retailers. Readers can understand what categories, channels, companies, and consumers will drive the success of Hot Drinks market in Canada through GlobalData’s detailed and robust data, expert insight, and case studies. GlobalData’s Top Growth Opportunity reports use a risk versus reward opportunity model to identify the best growth markets for Hot Drinks producers. Through...
-
Analyst Opinions
Targeting Consumer Needs for Energy and Sports Nutrition: How to effectively target mainstream consumer needs through innovation
"Targeting Consumer Needs for Energy and Sports Nutrition", report explores innovation opportunities for food, drink brands, sports nutrition, and energy food and drink brands. Demand for energy and sports nutrition has moved from niche to mainstream, as consumers turn to such products to facilitate lifestyle needs beyond just sports and exercise.
-
Product Insights
Hepatitis B Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Hepatitis B Global Clinical Trials Review, H2, 2016" provides an overview of Hepatitis B clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis B. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Hepatitis D Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Hepatitis D Global Clinical Trials Review, H2, 2016" provides an overview of Hepatitis D clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis D. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...